News and Updates

A new study explores the performance of Nanox's AI solution in cardiac imaging, aiming to enhance diagnostic speed and accuracy in cardiovascular care.

Explore how a unique Delhi puppet show is blending traditional performance art with the complexities of DNA and genetics to spark new scientific interest.

A breakthrough clinical trial offers new hope for babies with fetal kidney failure, potentially transforming the prognosis for congenital renal conditions.

Insilico Medicine’s AI-discovered drug, Rentosertib, enters Phase III trials for IPF. A breakthrough in AI-driven drug development for lung fibrosis.

Seegene launches a landmark one-million-patient global study to set new international standards for molecular diagnostic testing and syndromic accuracy.

HHS launches a new national pledge to improve hospital food quality, prioritizing patient nutrition to support recovery and reduce chronic disease outcomes.

New Phase 3 data reveals that XIAFLEX significantly improves symptoms of plantar fibromatosis, offering a potential non-surgical breakthrough for patients.

OKYO Pharma receives positive FDA feedback on its lead ocular candidate, OK-101. Learn how this regulatory milestone impacts the future of dry eye treatment.

Turn Therapeutics stock surges after promising AD clinical trial results. Learn how the company is expanding its pipeline to tackle chronic skin conditions.

Theriva Biologics gains Spanish approval for Phase 2a trials of VCN-01. Learn how this novel oncolytic virus targets treatment-resistant pancreatic cancer.